Clinical Trials on Drug-coated Balloon in Ireland

Total 37 results

University College Cork

Completed

Prevention of Adverse Drug Events (ADEs) in Hospitalised Older Patients

Adverse Drug Reaction

Ireland
University College Cork
University of East Anglia; Hospital Universitario Ramon y Cajal; University Ghent and other collaborators

Completed

Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Older peRsons (SENATOR)

Adverse Drug Reactions

Ireland
University College Cork

Completed

Adverse Drug Event Prevention Using Structured Pharmacist Review

Adverse Drug Reactions

Ireland
Sumitomo Pharma America, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Drug Interaction Potential of Napabucasin in Healthy Volunteers

Drug-drug Interactions

United States
Brown University
National Institute on Drug Abuse (NIDA)

Completed

The Rhode Island Prescription and Illicit Drug Study (RAPIDS)

Drug Overdose | Opioid Overdose

United States
University College Cork

Unknown

Discontinuation of Long-term Medications in Older People Entering Nursing Home Care (STOPPFrail)

Frail Elderly Syndrome | Drug-Related Side Effects and Adverse Reactions | Polypharmacy | Inappropriate Prescribing

Ireland
Brown University
National Institute on Drug Abuse (NIDA); New York University

Active, not recruiting

Preventing Overdose Using Information and Data From the Environment (PROVIDENT)

Drug Overdose | Opioid Overdose

United States
Jørgen Bjerggaard Jensen
Odense University Hospital; Karolinska University Hospital; Zealand University... and other collaborators

Recruiting

NORTH-REG Dwell-Time Study

Side Effect of Drug

Denmark, Sweden, Iceland
Helsinki University Central Hospital
Tampere University Hospital

Enrolling by invitation

Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study (CardioSwitch)

Solid Tumor

Denmark, Norway, Sweden, Finland, Netherlands, Iceland, Ireland
National University of Ireland, Galway, Ireland
Clinical Research Facility Galway; CORRIB Research Centre for Advanced Imaging...

Recruiting

Understanding CARdiac Events in Breast Cancer (UCARE)

Heart Failure | Breast Cancer | Cardiomyopathies | Cardiotoxicity | Chemotherapeutic Toxicity | Oncology

Ireland
University Hospital Inselspital, Berne
UMC Utrecht; Cliniques universitaires Saint-Luc- Université Catholique de Louvain and other collaborators

Completed

OPtimising thERapy to Prevent Avoidable Hospital Admissions in the Multimorbid Older People (OPERAM)

3 or More Chronic Conditions for 6 Months or Longer | 5 or More Regular Drugs

Belgium, Ireland, Netherlands, Switzerland
University Hospital Inselspital, Berne
UMC Utrecht; Cliniques universitaires Saint-Luc- Université Catholique de Louvain and other collaborators

Completed

Health Economic Evaluation Alongside the OPERAM Trial

3 or More Chronic Conditions for 6 Months or Longer | 5 or More Regular Drugs

Belgium, Ireland, Netherlands, Switzerland
Renaissance RX
Syntactx

Unknown

Diagnosing Adverse Drug Reactions Registry (DART)

Genetics of Drug Metabolism

United States
University of Rhode Island

Recruiting

Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents

Alcohol Drinking | Tobacco Use | Drug Use

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Treatment of Acute Lymphoblastic Leukemia in Children

Leukemia | Drug/Agent Toxicity by Tissue/Organ

United States, Canada
Cancer Trials Ireland

Completed

CADY Study ICORG 08-01

Breast Cancer | Cardiac Toxicity

Ireland
Baystate Medical Center
National Institute on Drug Abuse (NIDA); The Miriam Hospital; Boston Medical... and other collaborators

Completed

Prescribe to Save Lives (PTSL)

Opioid-Related Disorders | Drug Overdose

United States
Brown University

Completed

Rapid Self-Testing to Prevent Fentanyl Overdose Among Young People Who Use Drugs (RAPiDS2)

Accidental Overdose of Opiate

United States
Pro-Change Behavior Systems
IMS Health

Completed

Iwin: Individual Well-Being Navigator

Other Drug Substance Abuse

United States
Rhode Island Hospital
National Institute on Drug Abuse (NIDA)

Completed

Increasing Viral Testing in the Emergency Department (InVITED)

Hepatitis C | HIV | Drug Use

United States
UCB Biopharma SRL

Terminated

A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy (DUET)

Drug-Resistant Epilepsy | Focal-Onset Seizures

United States, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerlan... and more
UCB Biopharma SRL

Terminated

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Drug-Resistant Epilepsy | Focal-Onset Seizures

United States, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Lithuania, Mexico, Poland, Romania, Serbia, Slovakia, Spain, Turk... and more
University College, London
University of Oxford; University of Plymouth; University of Birmingham; University... and other collaborators

Completed

Use of Decision Support in the Management of Labour (INFANT)

Fetal Intrauterine Distress First Noted During Labor and or Delivery in Liveborn Infant | Team Based on Their Existing Guidelines and the Woman Consents to Have EFM and EFM is | Possible

United Kingdom, Ireland
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Colorectal Cancer | Anal Cancer | Drug/Agent Toxicity by Tissue/Organ | Radiation Enteritis

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Lung Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/Organ

United States, Canada
MedtronicNeuro

Completed

Implantable Systems Performance Registry (ISPR)

Deep Brain Stimulation | Spinal Cord Stimulation | Sacral Neuromodulation | Drug Infusion (Implantable Pumps)

United States, France, Spain, Germany, United Kingdom, Italy, Austria
Addex Pharma S.A.

Recruiting

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Parkinson Disease | Dyskinesias | Dyskinesia, Drug-Induced

United States
Neurocrine Biosciences

Completed

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Tardive Dyskinesia

United States, Puerto Rico
Ipsen

Terminated

Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome (CAMPANULA)

Carcinoid Syndrome

Spain, Belgium, Ireland, Czechia, Israel, France, United Kingdom, Latvia, Germany, Russian Federation, Slovakia, Italy, Netherlands, Finland, Austria, Poland, Sweden, Ukraine
Member Companies of the Opioid PMR Consortium

Terminated

Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain

Opioid-Related Disorders | Drug Abuse | Opiate Addiction | Narcotic Abuse

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

Unspecified Childhood Solid Tumor, Protocol Specific | Ototoxicity

Canada, United States, Australia
University of South Florida
National Cancer Institute (NCI)

Completed

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Breast Cancer | Cardiac Toxicity

United States
ImmunoGen, Inc.

Not yet recruiting

A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression

Recurrent Ovarian Cancer | Folate Receptor-Alpha Positive

United States, Spain, Australia, Belgium, Canada, France, Ireland, Italy
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease

Lymphoma | Cardiac Toxicity

United States, Canada, Switzerland
SWOG Cancer Research Network
National Cancer Institute (NCI)

Recruiting

S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer

Cardiotoxicity | Recurrent Breast Carcinoma | HER2/Neu Positive | Metastatic Malignant Neoplasm in the Brain | Stage IV Breast Cancer AJCC v6 and v7

United States, Korea, Republic of, Puerto Rico, Saudi Arabia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Sarcoma | Ovarian Cancer | Brain Tumor | Ototoxicity | Neuroblastoma | Liver Cancer | Central Nervous System Tumor | Extragonadal Germ Cell Tumor | Childhood Germ Cell Tumor

Canada, United States, Australia
National Cancer Institute (NCI)

Active, not recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Malignant Solid Neoplasm | Nasopharyngeal Carcinoma | Adenoid Cystic Carcinoma | Transitional Cell Carcinoma | Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Chordoma | Gestational Trophoblastic Tumor | Pseudomyxoma Peritonei | Cervical Adenocarcinoma | Vaginal Adenocarcinoma | Vaginal Squamous Cell... and other conditions

United States, Guam

Clinical Trials on Drug-coated Balloon in Ireland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations